|
| ||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||
|
| ||||||||||||||||||||||||
|
The Harvard School of Public Health invites you to participate in a study of Bronchioloalveolar Cell Carcinoma (BAC) of the Lung. Recent research studies have observed an increase of the BAC cell type within adenocarcinoma, currently the most widespread lung cancer subtype. BAC has unique features, such as involvement of both lungs, comparatively slow course, and increasing incidence over the past 20 years. Although changes in cigarette types and in smoking patterns may explain some of the shifts in the major subtypes, they do not appear to account for the apparent increase in BAC—a type that appears in non-smokers as well. Although lung cancer is heavily studied, we know very little about BAC. This research study will help us to understand the epidemiology of BAC, how we might develop ways of preventing it, and also about its molecular characteristics in order to help develop more effective treatments. **We have reached our recruitment target and are now finishing analyses of de-identified data. No publications to date.** Who is Eligible?If you are over 18 years of age and have confirmed lung cancer that has been described as either BAC or adenocarcinoma, you may qualify for this study. BAC patients of all ethnicities and genders are invited to participate. We will screen any individuals who believe that their their physicians have used the terms “bronchoalveolar,” “BAC,” “bronchioloalveolar lung cancer,” or some variation of these terms, to describe their lung cancer. In addition we will screen patients with lungs cancers that have been identified primarily as adenocarcinomas, if the description in the pathology report describes some component of BAC. Please note that adenocarcinomas that do not have any component of BAC will not qualify for this study. Return to Top What Will Happen? 1. Completing a questionnaire about your diet, medical history, and the history of your work and living environments. 2. Obtaining a small sample (two tablespoons) of your blood, which will be sent to Harvard for analysis. 3. Giving permission for us to review your medical records and to obtain a sample of your lung tissue from your hospital or clinic. This sample will also be sent to Harvard for analysis. Please note that you DO NOT need to provide a new sample of the tumor for this study. For our research, we will use tissue obtained from previous procedures and surgeries you may have had. Please be assured that you will not be charged for any part of this study, including analysis of your tissue sample. We will cover all postage expenses for your consent form, and for the shipment of your samples, questionnaires, and consent medical authorization release form. You will be paid $25 for your participation in this study. How Can I Participate?
Please send completed consent form to: You will be enrolled in the study when we have received your signed consent form. At that time, we will send you the questionnaire and instructions for obtaining your tissue sample from your hospital or clinic. When we receive your tissue samples, we will send you a check in the amount of $25. If you have any questions about this study, please contact Starr Sumpter at (617)432-1261, or by e-mail at ssumpter@hsph.harvard.edu. Return to Top |
||||||||||||||||||||||||
| Lung Cancer Home | Contact Us | HSPH Home | ||||||||||||||||||||||||
|
Harvard School of Public Health | ||||||||||||||||||||||||